Detalles de la búsqueda
1.
First- versus Third-Generation EGFR Tyrosine Kinase Inhibitors in EGFR-Mutated Non-Small Cell Lung Cancer Patients with Brain Metastases.
Cancers (Basel)
; 15(8)2023 Apr 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-37190312
2.
Combination of EGFR-Directed Tyrosine Kinase Inhibitors (EGFR-TKI) with Radiotherapy in Brain Metastases from Non-Small Cell Lung Cancer: A 2010-2019 Retrospective Cohort Study.
Cancers (Basel)
; 15(11)2023 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37296975
3.
Neutrophil to lymphocyte ratio influences impact of steroids on efficacy of immune checkpoint inhibitors in lung cancer brain metastases.
Sci Rep
; 11(1): 7490, 2021 04 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33820922
4.
Impact of KRAS mutation status on the efficacy of immunotherapy in lung cancer brain metastases.
Sci Rep
; 11(1): 18174, 2021 09 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-34518623
5.
Anemia from A to zinc: Hypocupremia in the setting of gastric bypass and zinc excess.
Clin Case Rep
; 8(4): 745-750, 2020 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-32274050
6.
Optimal management of atypical hemolytic uremic disease: challenges and solutions.
Int J Nephrol Renovasc Dis
; 12: 183-204, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31564951
7.
Author Correction: Impact of KRAS mutation status on the efficacy of immunotherapy in lung cancer brain metastases.
Sci Rep
; 12(1): 1147, 2022 Jan 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-35039661
8.
Author Correction: Neutrophil to lymphocyte ratio influences impact of steroids on efficacy of immune checkpoint inhibitors in lung cancer brain metastases.
Sci Rep
; 12(1): 1201, 2022 Jan 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-35043001
9.
Author Correction: Neutrophil to lymphocyte ratio influences impact of steroids on efficacy of immune checkpoint inhibitors in lung cancer brain metastases.
Sci Rep
; 11(1): 18212, 2021 Sep 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34497288
Resultados
1 -
9
de 9
1
Próxima >
>>